Skip to main content

Table 1 Key inclusion and exclusion criteria

From: Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

Key inclusion criteria

Key exclusion criteria

Patients must be at least 18 years of age

Unequivocal demonstration of distant metastatic disease

Pathologically confirmed HPV + OPC1

Non-HPV16/18 subtype

Subjects with AJCC (8th edition, 2018) N1 (if single lymph node must be \(\ge\) 3 cm), N2-N3 nodal disease or T3-T4 primary tumor

N2-3 (or nodal conglomerate \(\ge\) 6 cm)

Measurable disease by RECIST 1.1 criteria

 > 20 pack year smoking history

No previous radiation or chemotherapy for head and neck cancer

HPV18 subtype

No complete surgical resection for head and neck cancer

Unidentifiable primary site

ECOG performance status 0–1

Intercurrent medical illness which would impair patient tolerance to therapy or limit survival

Normal organ function

History of HIV, active hepatitis B or hepatitis C

  1. 1Defined by p16 positivity by immunohistochemistry with confirmation with HPV PCR confirming HPV subtype